Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses

Several approaches have produced an effective vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since millions of people are exposed to influenza virus and SARS-CoV-2, it is of great interest to develop a two-in-one vaccine that will be able to protect against infection o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bommireddy, Ramireddy, Stone, Shannon, Bhatnagar, Noopur, Kumari, Pratima, Munoz, Luis E., Oh, Judy, Kim, Ki-Hye, Berry, Jameson T. L., Jacobsen, Kristen M., Jaafar, Lahcen, Naing, Swe-Htet, Blackerby, Allison N., der Gaag, Tori Van, Wright, Chloe N., Lai, Lilin, Pack, Christopher D., Ramachandiran, Sampath, Suthar, Mehul S., Kang, Sang-Moo, Kumar, Mukesh, Reddy, Shaker J. C., Selvaraj, Periasamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230705/
https://www.ncbi.nlm.nih.gov/pubmed/35746552
http://dx.doi.org/10.3390/vaccines10060944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230705/
https://www.ncbi.nlm.nih.gov/pubmed/35746552
http://dx.doi.org/10.3390/vaccines10060944

Ejemplares similares